Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGaspar, N.
dc.contributor.authorCampbell Hewson, Quentin
dc.contributor.authorGallego Melcón, Soledad
dc.contributor.authorLocatelli, F.
dc.contributor.authorVenkatramani, R.
dc.contributor.authorHecker-Nolting, S.
dc.date.accessioned2022-04-25T13:16:10Z
dc.date.available2022-04-25T13:16:10Z
dc.date.issued2021-10
dc.identifier.citationGaspar N, Campbell-Hewson Q, Gallego Melcon S, Locatelli F, Venkatramani R, Hecker-Nolting S, et al. Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050). ESMO Open. 2021 Oct 1;6(5):100250.
dc.identifier.issn2059-7029
dc.identifier.urihttps://hdl.handle.net/11351/7399
dc.descriptionOsteosarcoma; Pediàtrica; Tumors sòlids
dc.description.sponsorshipThis work was supported by Eisai Inc., Woodcliff Lake, NJ, USA and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesESMO Open;6(5)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectOssos - Malalties, en els infants
dc.subjectOssos - Càncer - Tractament
dc.subjectQuimioteràpia combinada
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshBone Neoplasms
dc.subject.mesh/drug therapy
dc.titlePhase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1016/j.esmoop.2021.100250
dc.subject.decsprotocolos de quimioterapia antineoplásica combinada
dc.subject.decsneoplasias óseas
dc.subject.decs/farmacoterapia
dc.relation.publishversionhttps://doi.org/10.1016/j.esmoop.2021.100250
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Gaspar N] Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Campus, Villejuif, France. [Campbell-Hewson Q] The Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, UK. [Gallego Melcon S] Servei d'Oncologia i Hematologia Pediàtrica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Locatelli F] Department of Pediatric Hematology and Oncology, Ospedale Pediatrico Bambino Gesù, University of Rome, Rome, Italy. [Venkatramani R] Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, USA. [Hecker-Nolting S] Department of Pediatric Oncology, Hematology, Immunology, Klinikum Stuttgart - Olgahospital, Stuttgart, Germany
dc.identifier.pmid34562750
dc.identifier.wos000704803800003
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple